Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 12
- +3 vs. Q3 2023
- Portfolio value
- $18.5M
- −$7.80M (−29.6%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| XERSXeris Biopharma Holdings, Inc. | COM | 5,641,920 | $13.3M | 71.6% | 00.0% | Unchanged | History |
| SVRASavara Inc | COM | 353,441 | $1.66M | 9.0% | −2,960,161−89.3% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 1,318,967 | $1.31M | 7.1% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 1,322 | $628.1K | 3.4% | +1,322 | New | History |
| MTEMMolecular Templates, Inc. | COM NEW | 136,866 | $510.5K | 2.8% | 00.0% | Unchanged | History |
| BRK.BBerkshire Hathaway Inc | Stock | 1,035 | $369.3K | 2.0% | +1,035 | New | History |
| APGEApogee Therapeutics, Inc. | COM | 7,353 | $205.4K | 1.1% | −5,119−41.0% | Reduced | History |
| ABVXAbivax S.A. | SPONSORED ADS | 16,743 | $179.1K | 1.0% | +16,743 | New | History |
| LXEOLexeo Therapeutics, Inc. | COM | 10,319 | $138.5K | 0.7% | +10,319 | New | History |
| HARPHarpoon Therapeutics, Inc. | COM NEW | 13,176 | $129.3K | 0.7% | +13,176 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 43,465 | $67.8K | 0.4% | −43,308−49.9% | Reduced | History |
| ALLKAllakos Inc. | COM | 24,710 | $67.5K | 0.4% | −24,619−49.9% | Reduced | History |
Sold out since Q3 2023 (2)
Positions held at the end of Q3 2023 that are gone from this filing.